Theriva Biologics, Inc. Schedule 13G/A Filing

The Schedule 13G/A filing by Theriva Biologics, Inc. discloses the beneficial ownership of common stock by Empery Asset Management, LP, Ryan M. Lane, and Martin D. Hoe. The filing indicates that these entities and individuals collectively own 4.99% of the company's common stock, which is issuable upon the exercise of warrants. The warrants are subject to a blocker provision that prevents the Reporting Persons from exercising the warrants to the extent that they would beneficially own more than 4.99% of the outstanding shares of common stock. The filing also provides details on the citizenship and business addresses of the Reporting Persons, as well as their respective roles in the ownership structure. The filing is an amendment to a previous submission and is made pursuant to Rule 13d-1(b).